lhe new highpotency neuroleptic drugs used i n t h e long-term treatment of psychiatric p a t i e n t s have v i r t u a l l y eliminated concern about many formerly important adverse effects other than t a r d i v e dyskinesia (TD). It has been postulated that t h e dopaminergic-cholinergic balance influences t h e dyskinetic movements of TD. Anticholinergic drugs have been used i n t h e treatment of parkinsonian as w e l l as acute dystonic symptoms caused by neuroleptic drugs (Paldessarini 1979, Gerlach 1979. C h t h e o t h e r hand, anticholinergic treatment has been observed t o enhance t h e signs of TD (Burnett e t a l . 1980, Hollister 1980). lhe aim of t h i s study was t o examine t h e effect of cessation of a n t icholinergic drugs on t h e TD i n psychiatric p a t i e n t s on long-standing neurol e p t i c medication. 13 chronic psychiatric p a t i e n t s , whose diagnoses were schizophrenia i n 12 and chronic depressive syndrome i n one of t h e cases, were included i n t h e study. lhe mean age of t h e p a t i e n t s was 55,8 years and t h e i r psychia t r i c disease had l a s t e d For an awerage of 26,8 years. e r g i c (AC) as w e l l as t h e neuroleptic treatment had been unchanged f o r a t least two months before t h e study. ?he t a r d i v e dyskinesia syndrome was o r a l i n 7, and generalized type i n 6 of t h e cases. Furthermore, parkinsonian s i g n s were observed i n 4 of t h e 13 cases during AC treatment. lhe AC treatment was biperiden 2-6 mglday i n 10, orphenadine 100-150 mg/day i n 2, and methixene 30 mg/day i n one of t h e 13 p a t i e n t s . 'he indication f o r A C treatment had been manifest parkinsonian s i g n s caused by neuroleptics i n 7 and t h e prophylaxis of these signs i n 6 cases. lhe grade of TD before and 1-2 weeks a f t e r withdrawing t h e anticholine r g i c s w a s estimated using t h e AIMS scale (Fann e t a l . 1980) as demonstrat e d i n Table 1. or' t h e A I K S grades were observed ( p c : 0 , 0 5 ; X t e s t ) , with t o t a l disappearance of t h e dyskinetic movements i n two cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.